Industry Research Reports
Home > Reports > Medical Devices & Consumables > Human Serum and Plasma- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Human Serum and Plasma- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Industry: Medical Devices & Consumables
Published Date: 2024-10-01
Pages: 94 Pages
Report ld: 3335727
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Human plasma is an important component of blood. It is a liquid without cell components obtained by centrifugation after the whole blood leaves the blood vessels and is anticoagulated. Human serum refers to the light yellow transparent liquid separated from the plasma by removing fibrinogen after blood coagulation, or plasma without fibrinogen. It is an invisible component of blood and is different from plasma in composition.
The global market for Human Serum and Plasma was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
North American market for Human Serum and Plasma was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Human Serum and Plasma was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Human Serum and Plasma was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Human Serum and Plasma include Akron, Baxter, Cytiva, Merck Millipore, Monobind, SeraCare, TCS Biosciences Ltd, Thermo Fisher, Trina Bioreactives, Zen-Bio, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Human Serum and Plasma, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Human Serum and Plasma by region & country, by Type, and by Application.
The Human Serum and Plasma market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Serum and Plasma.
MARKET SEGMENTATION
By Company
- Akron
- Baxter
- Cytiva
- Merck Millipore
- Monobind
- SeraCare
- TCS Biosciences Ltd
- Thermo Fisher
- Trina Bioreactives
- Zen-Bio
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Fresh Human Serum and Plasma
- Frozen Human Serum and Plasma
Segment by Application
- In Vitro Diagnostics
- Vaccines and Antibodies
- Cell Culture
- Clinical Research
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Human Serum and Plasma manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Human Serum and Plasma in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Human Serum and Plasma in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Human Serum and Plasma Product Introduction
1.2 Global Human Serum and Plasma Market Size Forecast
1.2.1 Global Human Serum and Plasma Sales Value (2019-2030)
1.2.2 Global Human Serum and Plasma Sales Volume (2019-2030)
1.2.3 Global Human Serum and Plasma Sales Price (2019-2030)
1.3 Human Serum and Plasma Market Trends & Drivers
1.3.1 Human Serum and Plasma Industry Trends
1.3.2 Human Serum and Plasma Market Drivers & Opportunity
1.3.3 Human Serum and Plasma Market Challenges
1.3.4 Human Serum and Plasma Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Human Serum and Plasma Players Revenue Ranking (2023)
2.2 Global Human Serum and Plasma Revenue by Company (2019-2024)
2.3 Global Human Serum and Plasma Players Sales Volume Ranking (2023)
2.4 Global Human Serum and Plasma Sales Volume by Company Players (2019-2024)
2.5 Global Human Serum and Plasma Average Price by Company (2019-2024)
2.6 Key Manufacturers Human Serum and Plasma Manufacturing Base and Headquarters
2.7 Key Manufacturers Human Serum and Plasma Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Human Serum and Plasma
2.9 Human Serum and Plasma Market Competitive Analysis
2.9.1 Human Serum and Plasma Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Human Serum and Plasma Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Serum and Plasma as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Fresh Human Serum and Plasma
3.1.2 Frozen Human Serum and Plasma
3.2 Global Human Serum and Plasma Sales Value by Type
3.2.1 Global Human Serum and Plasma Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Human Serum and Plasma Sales Value, by Type (2019-2030)
3.2.3 Global Human Serum and Plasma Sales Value, by Type (%) (2019-2030)
3.3 Global Human Serum and Plasma Sales Volume by Type
3.3.1 Global Human Serum and Plasma Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Human Serum and Plasma Sales Volume, by Type (2019-2030)
3.3.3 Global Human Serum and Plasma Sales Volume, by Type (%) (2019-2030)
3.4 Global Human Serum and Plasma Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 In Vitro Diagnostics
4.1.2 Vaccines and Antibodies
4.1.3 Cell Culture
4.1.4 Clinical Research
4.1.5 Others
4.2 Global Human Serum and Plasma Sales Value by Application
4.2.1 Global Human Serum and Plasma Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Human Serum and Plasma Sales Value, by Application (2019-2030)
4.2.3 Global Human Serum and Plasma Sales Value, by Application (%) (2019-2030)
4.3 Global Human Serum and Plasma Sales Volume by Application
4.3.1 Global Human Serum and Plasma Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Human Serum and Plasma Sales Volume, by Application (2019-2030)
4.3.3 Global Human Serum and Plasma Sales Volume, by Application (%) (2019-2030)
4.4 Global Human Serum and Plasma Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Human Serum and Plasma Sales Value by Region
5.1.1 Global Human Serum and Plasma Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Human Serum and Plasma Sales Value by Region (2019-2024)
5.1.3 Global Human Serum and Plasma Sales Value by Region (2025-2030)
5.1.4 Global Human Serum and Plasma Sales Value by Region (%), (2019-2030)
5.2 Global Human Serum and Plasma Sales Volume by Region
5.2.1 Global Human Serum and Plasma Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Human Serum and Plasma Sales Volume by Region (2019-2024)
5.2.3 Global Human Serum and Plasma Sales Volume by Region (2025-2030)
5.2.4 Global Human Serum and Plasma Sales Volume by Region (%), (2019-2030)
5.3 Global Human Serum and Plasma Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Human Serum and Plasma Sales Value, 2019-2030
5.4.2 North America Human Serum and Plasma Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Human Serum and Plasma Sales Value, 2019-2030
5.5.2 Europe Human Serum and Plasma Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Human Serum and Plasma Sales Value, 2019-2030
5.6.2 Asia Pacific Human Serum and Plasma Sales Value by Region (%), 2023 VS 2030
5.7 South America
5.7.1 South America Human Serum and Plasma Sales Value, 2019-2030
5.7.2 South America Human Serum and Plasma Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Human Serum and Plasma Sales Value, 2019-2030
5.8.2 Middle East & Africa Human Serum and Plasma Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Human Serum and Plasma Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Human Serum and Plasma Sales Value
6.2.1 Key Countries/Regions Human Serum and Plasma Sales Value, 2019-2030
6.2.2 Key Countries/Regions Human Serum and Plasma Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Human Serum and Plasma Sales Value, 2019-2030
6.3.2 United States Human Serum and Plasma Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Human Serum and Plasma Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Human Serum and Plasma Sales Value, 2019-2030
6.4.2 Europe Human Serum and Plasma Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Human Serum and Plasma Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Human Serum and Plasma Sales Value, 2019-2030
6.5.2 China Human Serum and Plasma Sales Value by Type (%), 2023 VS 2030
6.5.3 China Human Serum and Plasma Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Human Serum and Plasma Sales Value, 2019-2030
6.6.2 Japan Human Serum and Plasma Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Human Serum and Plasma Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Human Serum and Plasma Sales Value, 2019-2030
6.7.2 South Korea Human Serum and Plasma Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Human Serum and Plasma Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Human Serum and Plasma Sales Value, 2019-2030
6.8.2 Southeast Asia Human Serum and Plasma Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Human Serum and Plasma Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Human Serum and Plasma Sales Value, 2019-2030
6.9.2 India Human Serum and Plasma Sales Value by Type (%), 2023 VS 2030
6.9.3 India Human Serum and Plasma Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Akron
7.1.1 Akron Company Information
7.1.2 Akron Introduction and Business Overview
7.1.3 Akron Human Serum and Plasma Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Akron Human Serum and Plasma Product Offerings
7.1.5 Akron Recent Development
7.2 Baxter
7.2.1 Baxter Company Information
7.2.2 Baxter Introduction and Business Overview
7.2.3 Baxter Human Serum and Plasma Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Baxter Human Serum and Plasma Product Offerings
7.2.5 Baxter Recent Development
7.3 Cytiva
7.3.1 Cytiva Company Information
7.3.2 Cytiva Introduction and Business Overview
7.3.3 Cytiva Human Serum and Plasma Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Cytiva Human Serum and Plasma Product Offerings
7.3.5 Cytiva Recent Development
7.4 Merck Millipore
7.4.1 Merck Millipore Company Information
7.4.2 Merck Millipore Introduction and Business Overview
7.4.3 Merck Millipore Human Serum and Plasma Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Merck Millipore Human Serum and Plasma Product Offerings
7.4.5 Merck Millipore Recent Development
7.5 Monobind
7.5.1 Monobind Company Information
7.5.2 Monobind Introduction and Business Overview
7.5.3 Monobind Human Serum and Plasma Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Monobind Human Serum and Plasma Product Offerings
7.5.5 Monobind Recent Development
7.6 SeraCare
7.6.1 SeraCare Company Information
7.6.2 SeraCare Introduction and Business Overview
7.6.3 SeraCare Human Serum and Plasma Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 SeraCare Human Serum and Plasma Product Offerings
7.6.5 SeraCare Recent Development
7.7 TCS Biosciences Ltd
7.7.1 TCS Biosciences Ltd Company Information
7.7.2 TCS Biosciences Ltd Introduction and Business Overview
7.7.3 TCS Biosciences Ltd Human Serum and Plasma Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 TCS Biosciences Ltd Human Serum and Plasma Product Offerings
7.7.5 TCS Biosciences Ltd Recent Development
7.8 Thermo Fisher
7.8.1 Thermo Fisher Company Information
7.8.2 Thermo Fisher Introduction and Business Overview
7.8.3 Thermo Fisher Human Serum and Plasma Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Thermo Fisher Human Serum and Plasma Product Offerings
7.8.5 Thermo Fisher Recent Development
7.9 Trina Bioreactives
7.9.1 Trina Bioreactives Company Information
7.9.2 Trina Bioreactives Introduction and Business Overview
7.9.3 Trina Bioreactives Human Serum and Plasma Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Trina Bioreactives Human Serum and Plasma Product Offerings
7.9.5 Trina Bioreactives Recent Development
7.10 Zen-Bio
7.10.1 Zen-Bio Company Information
7.10.2 Zen-Bio Introduction and Business Overview
7.10.3 Zen-Bio Human Serum and Plasma Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 Zen-Bio Human Serum and Plasma Product Offerings
7.10.5 Zen-Bio Recent Development
8 Industry Chain Analysis
8.1 Human Serum and Plasma Industrial Chain
8.2 Human Serum and Plasma Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Human Serum and Plasma Sales Model
8.5.2 Sales Channel
8.5.3 Human Serum and Plasma Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Human Serum and Plasma Market Trends
Table 2. Human Serum and Plasma Market Drivers & Opportunity
Table 3. Human Serum and Plasma Market Challenges
Table 4. Human Serum and Plasma Market Restraints
Table 5. Global Human Serum and Plasma Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Human Serum and Plasma Revenue Market Share by Company (2019-2024)
Table 7. Global Human Serum and Plasma Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Human Serum and Plasma Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Human Serum and Plasma Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Human Serum and Plasma Manufacturing Base and Headquarters
Table 11. Key Manufacturers Human Serum and Plasma Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Human Serum and Plasma
Table 13. Global Human Serum and Plasma Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Serum and Plasma as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Serum and Plasma Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Human Serum and Plasma Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Human Serum and Plasma Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Human Serum and Plasma Sales Market Share in Value by Type (2019-2024)
Table 20. Global Human Serum and Plasma Sales Market Share in Value by Type (2025-2030)
Table 21. Global Human Serum and Plasma Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Human Serum and Plasma Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Human Serum and Plasma Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Human Serum and Plasma Sales Market Share in Volume by Type (2019-2024)
Table 25. Global Human Serum and Plasma Sales Market Share in Volume by Type (2025-2030)
Table 26. Global Human Serum and Plasma Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Human Serum and Plasma Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Human Serum and Plasma Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Human Serum and Plasma Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Human Serum and Plasma Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Human Serum and Plasma Sales Market Share in Value by Application (2019-2024)
Table 32. Global Human Serum and Plasma Sales Market Share in Value by Application (2025-2030)
Table 33. Global Human Serum and Plasma Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Human Serum and Plasma Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Human Serum and Plasma Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Human Serum and Plasma Sales Market Share in Volume by Application (2019-2024)
Table 37. Global Human Serum and Plasma Sales Market Share in Volume by Application (2025-2030)
Table 38. Global Human Serum and Plasma Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Human Serum and Plasma Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Human Serum and Plasma Sales Value by Region, (2019 VS 2023 VS 2030) & (US$ Million)
Table 41. Global Human Serum and Plasma Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Human Serum and Plasma Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Human Serum and Plasma Sales Value by Region (2019-2024) & (%)
Table 44. Global Human Serum and Plasma Sales Value by Region (2025-2030) & (%)
Table 45. Global Human Serum and Plasma Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Human Serum and Plasma Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Human Serum and Plasma Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Human Serum and Plasma Sales Volume by Region (2019-2024) & (%)
Table 49. Global Human Serum and Plasma Sales Volume by Region (2025-2030) & (%)
Table 50. Global Human Serum and Plasma Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Human Serum and Plasma Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Human Serum and Plasma Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Human Serum and Plasma Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Human Serum and Plasma Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Human Serum and Plasma Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Human Serum and Plasma Sales Volume, (2025-2030) & (K Units)
Table 57. Akron Company Information
Table 58. Akron Introduction and Business Overview
Table 59. Akron Human Serum and Plasma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Akron Human Serum and Plasma Product Offerings
Table 61. Akron Recent Development
Table 62. Baxter Company Information
Table 63. Baxter Introduction and Business Overview
Table 64. Baxter Human Serum and Plasma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Baxter Human Serum and Plasma Product Offerings
Table 66. Baxter Recent Development
Table 67. Cytiva Company Information
Table 68. Cytiva Introduction and Business Overview
Table 69. Cytiva Human Serum and Plasma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Cytiva Human Serum and Plasma Product Offerings
Table 71. Cytiva Recent Development
Table 72. Merck Millipore Company Information
Table 73. Merck Millipore Introduction and Business Overview
Table 74. Merck Millipore Human Serum and Plasma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Merck Millipore Human Serum and Plasma Product Offerings
Table 76. Merck Millipore Recent Development
Table 77. Monobind Company Information
Table 78. Monobind Introduction and Business Overview
Table 79. Monobind Human Serum and Plasma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Monobind Human Serum and Plasma Product Offerings
Table 81. Monobind Recent Development
Table 82. SeraCare Company Information
Table 83. SeraCare Introduction and Business Overview
Table 84. SeraCare Human Serum and Plasma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. SeraCare Human Serum and Plasma Product Offerings
Table 86. SeraCare Recent Development
Table 87. TCS Biosciences Ltd Company Information
Table 88. TCS Biosciences Ltd Introduction and Business Overview
Table 89. TCS Biosciences Ltd Human Serum and Plasma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. TCS Biosciences Ltd Human Serum and Plasma Product Offerings
Table 91. TCS Biosciences Ltd Recent Development
Table 92. Thermo Fisher Company Information
Table 93. Thermo Fisher Introduction and Business Overview
Table 94. Thermo Fisher Human Serum and Plasma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Thermo Fisher Human Serum and Plasma Product Offerings
Table 96. Thermo Fisher Recent Development
Table 97. Trina Bioreactives Company Information
Table 98. Trina Bioreactives Introduction and Business Overview
Table 99. Trina Bioreactives Human Serum and Plasma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Trina Bioreactives Human Serum and Plasma Product Offerings
Table 101. Trina Bioreactives Recent Development
Table 102. Zen-Bio Company Information
Table 103. Zen-Bio Introduction and Business Overview
Table 104. Zen-Bio Human Serum and Plasma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Zen-Bio Human Serum and Plasma Product Offerings
Table 106. Zen-Bio Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. Human Serum and Plasma Downstream Customers
Table 110. Human Serum and Plasma Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Serum and Plasma Product Picture
Figure 2. Global Human Serum and Plasma Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Human Serum and Plasma Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Human Serum and Plasma Sales Volume (2019-2030) & (K Units)
Figure 5. Global Human Serum and Plasma Sales Price (2019-2030) & (US$/Unit)
Figure 6. Human Serum and Plasma Report Years Considered
Figure 7. Global Human Serum and Plasma Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Human Serum and Plasma Players Sales Volume Ranking (2023) & (US$ Million)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Serum and Plasma Revenue in 2023
Figure 10. Human Serum and Plasma Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Fresh Human Serum and Plasma Picture
Figure 12. Frozen Human Serum and Plasma Picture
Figure 13. Global Human Serum and Plasma Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Human Serum and Plasma Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Human Serum and Plasma Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Human Serum and Plasma Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Human Serum and Plasma Price by Type (2019-2030) & (US$/Unit)
Figure 18. Product Picture of In Vitro Diagnostics
Figure 19. Product Picture of Vaccines and Antibodies
Figure 20. Product Picture of Cell Culture
Figure 21. Product Picture of Clinical Research
Figure 22. Product Picture of Others
Figure 23. Global Human Serum and Plasma Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 24. Global Human Serum and Plasma Sales Value Market Share by Application, 2023 & 2030
Figure 25. Global Human Serum and Plasma Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 26. Global Human Serum and Plasma Sales Volume Market Share by Application, 2023 & 2030
Figure 27. Global Human Serum and Plasma Price by Application (2019-2030) & (US$/Unit)
Figure 28. North America Human Serum and Plasma Sales Value (2019-2030) & (US$ Million)
Figure 29. North America Human Serum and Plasma Sales Value by Country (%), 2023 VS 2030
Figure 30. Europe Human Serum and Plasma Sales Value, (2019-2030) & (US$ Million)
Figure 31. Europe Human Serum and Plasma Sales Value by Country (%), 2023 VS 2030
Figure 32. Asia Pacific Human Serum and Plasma Sales Value, (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Human Serum and Plasma Sales Value by Region (%), 2023 VS 2030
Figure 34. South America Human Serum and Plasma Sales Value, (2019-2030) & (US$ Million)
Figure 35. South America Human Serum and Plasma Sales Value by Country (%), 2023 VS 2030
Figure 36. Middle East & Africa Human Serum and Plasma Sales Value, (2019-2030) & (US$ Million)
Figure 37. Middle East & Africa Human Serum and Plasma Sales Value by Country (%), 2023 VS 2030
Figure 38. Key Countries/Regions Human Serum and Plasma Sales Value (%), (2019-2030)
Figure 39. Key Countries/Regions Human Serum and Plasma Sales Volume (%), (2019-2030)
Figure 40. United States Human Serum and Plasma Sales Value, (2019-2030) & (US$ Million)
Figure 41. United States Human Serum and Plasma Sales Value by Type (%), 2023 VS 2030
Figure 42. United States Human Serum and Plasma Sales Value by Application (%), 2023 VS 2030
Figure 43. Europe Human Serum and Plasma Sales Value, (2019-2030) & (US$ Million)
Figure 44. Europe Human Serum and Plasma Sales Value by Type (%), 2023 VS 2030
Figure 45. Europe Human Serum and Plasma Sales Value by Application (%), 2023 VS 2030
Figure 46. China Human Serum and Plasma Sales Value, (2019-2030) & (US$ Million)
Figure 47. China Human Serum and Plasma Sales Value by Type (%), 2023 VS 2030
Figure 48. China Human Serum and Plasma Sales Value by Application (%), 2023 VS 2030
Figure 49. Japan Human Serum and Plasma Sales Value, (2019-2030) & (US$ Million)
Figure 50. Japan Human Serum and Plasma Sales Value by Type (%), 2023 VS 2030
Figure 51. Japan Human Serum and Plasma Sales Value by Application (%), 2023 VS 2030
Figure 52. South Korea Human Serum and Plasma Sales Value, (2019-2030) & (US$ Million)
Figure 53. South Korea Human Serum and Plasma Sales Value by Type (%), 2023 VS 2030
Figure 54. South Korea Human Serum and Plasma Sales Value by Application (%), 2023 VS 2030
Figure 55. Southeast Asia Human Serum and Plasma Sales Value, (2019-2030) & (US$ Million)
Figure 56. Southeast Asia Human Serum and Plasma Sales Value by Type (%), 2023 VS 2030
Figure 57. Southeast Asia Human Serum and Plasma Sales Value by Application (%), 2023 VS 2030
Figure 58. India Human Serum and Plasma Sales Value, (2019-2030) & (US$ Million)
Figure 59. India Human Serum and Plasma Sales Value by Type (%), 2023 VS 2030
Figure 60. India Human Serum and Plasma Sales Value by Application (%), 2023 VS 2030
Figure 61. Human Serum and Plasma Industrial Chain
Figure 62. Human Serum and Plasma Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Human Serum and Plasma market?
The top companies in the global Human Serum and Plasma market are Akron、Baxter、Cytiva.
Related Reports
Global Human Serum and Plasma Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Human Serum and Plasma market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 141
USD 4900.00
(Single User License)
Global Human Serum and Plasma Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Human Serum and Plasma market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 76
USD 4250.00
(Single User License)
Human Serum and Plasma- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Human Serum and Plasma was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 101
USD 3950.00
(Single User License)
Global Human Serum and Plasma Market Research Report 2026
The global Human Serum and Plasma market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 116
USD 2900.00
(Single User License)
Global Human Serum and Plasma Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Human Serum and Plasma market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 144
USD 4900.00
(Single User License)
Global Human Serum and Plasma Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Human Serum and Plasma market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 76
USD 4250.00
(Single User License)
Human Serum and Plasma - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Human Serum and Plasma was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 107
USD 3950.00
(Single User License)
Global Human Serum and Plasma Market Research Report 2025
The global market for Human Serum and Plasma was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 86
USD 2900.00
(Single User License)
Global Human Serum and Plasma Market Insights, Forecast to 2030
Human plasma is an important component of blood. It is a liquid without cell components obtained by centrifugation after the whole blood leaves the blood vessels and is anticoagulated. Human serum refers to the light yellow transparent liquid separated from the plasma by removing fibrinogen after blood coagulation, or plasma without fibrinogen. It is an invisible component of blood and is different from plasma in composition.
Published Date: 2024-10-01
Pages: 137
USD 4900.00
(Single User License)
Global Human Serum and Plasma Market Research Report 2024
Human plasma is an important component of blood. It is a liquid without cell components obtained by centrifugation after the whole blood leaves the blood vessels and is anticoagulated. Human serum refers to the light yellow transparent liquid separated from the plasma by removing fibrinogen after blood coagulation, or plasma without fibrinogen. It is an invisible component of blood and is different from plasma in composition.
Published Date: 2024-10-01
Pages: 83
USD 2900.00
(Single User License)
Global Human Serum and Plasma Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Human Serum and Plasma market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 141
USD 4900.00 (Single User License)Global Human Serum and Plasma Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Human Serum and Plasma market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 76
USD 4250.00 (Single User License)Human Serum and Plasma- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Human Serum and Plasma was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 101
USD 3950.00 (Single User License)Global Human Serum and Plasma Market Research Report 2026
The global Human Serum and Plasma market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 116
USD 2900.00 (Single User License)Global Human Serum and Plasma Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Human Serum and Plasma market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 144
USD 4900.00 (Single User License)Global Human Serum and Plasma Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Human Serum and Plasma market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 76
USD 4250.00 (Single User License)Human Serum and Plasma - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Human Serum and Plasma was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 107
USD 3950.00 (Single User License)Global Human Serum and Plasma Market Research Report 2025
The global market for Human Serum and Plasma was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 86
USD 2900.00 (Single User License)Global Human Serum and Plasma Market Insights, Forecast to 2030
Human plasma is an important component of blood. It is a liquid without cell components obtained by centrifugation after the whole blood leaves the blood vessels and is anticoagulated. Human serum refers to the light yellow transparent liquid separated from the plasma by removing fibrinogen after blood coagulation, or plasma without fibrinogen. It is an invisible component of blood and is different from plasma in composition.
Published: 2024-10-01
Pages: 137
USD 4900.00 (Single User License)Global Human Serum and Plasma Market Research Report 2024
Human plasma is an important component of blood. It is a liquid without cell components obtained by centrifugation after the whole blood leaves the blood vessels and is anticoagulated. Human serum refers to the light yellow transparent liquid separated from the plasma by removing fibrinogen after blood coagulation, or plasma without fibrinogen. It is an invisible component of blood and is different from plasma in composition.
Published: 2024-10-01
Pages: 83
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now